SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-518194
Filing Date
2016-03-25
Accepted
2016-03-25 16:23:36
Documents
4
Period of Report
2016-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d139910d8k.htm 8-K 19787
2 EX-5.1 d139910dex51.htm EX-5.1 4150
3 EX-10.1 d139910dex101.htm EX-10.1 102458
4 GRAPHIC g139910pill.jpg GRAPHIC 6843
  Complete submission text file 0001193125-16-518194.txt   137344
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 161529909
SIC: 2834 Pharmaceutical Preparations